210 related articles for article (PubMed ID: 3053747)
1. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
[TBL] [Abstract][Full Text] [Related]
2. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes.
Paolisso G; Sgambato S; Torella R; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1988 Jun; 66(6):1220-6. PubMed ID: 3286673
[TBL] [Abstract][Full Text] [Related]
3. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F
Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096
[TBL] [Abstract][Full Text] [Related]
4. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
[TBL] [Abstract][Full Text] [Related]
5. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
6. Effects of pulsatile delivery of insulin and glucagon in humans.
Paolisso G; Scheen AJ; Albert A; Lefebvre PJ
Am J Physiol; 1989 Nov; 257(5 Pt 1):E686-96. PubMed ID: 2688437
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin does not affect endogenous glucose production in type 2 diabetes mellitus.
Pereira Arias AM; Bisschop PH; Ackermans MT; Endert E; Romijn JA; Sauerwein HP
Horm Metab Res; 2001 Nov; 33(11):659-63. PubMed ID: 11733868
[TBL] [Abstract][Full Text] [Related]
8. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency.
Paolisso G; Scheen AJ; Giugliano D; Sgambato S; Albert A; Varricchio M; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1991 Mar; 72(3):607-15. PubMed ID: 1997515
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of pulsatile insulin infusion in the elderly.
Paolisso G; Salvatore T; Sgambato S; Torella R; Varricchio M; D'Onofrio F
Acta Endocrinol (Copenh); 1990 Jul; 123(1):19-23. PubMed ID: 1975147
[TBL] [Abstract][Full Text] [Related]
10. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
[TBL] [Abstract][Full Text] [Related]
11. Insulin effects on glucose kinetics in non-insulin-dependent diabetic patients with secondary failure to hypoglycaemic agents: role of different modes and rates of delivery.
Paolisso G; Sgambato S; Varricchio M; Scheen AJ; D'Onofrio F; Lefèbvre P
Eur J Med; 1992 Sep; 1(5):261-7. PubMed ID: 1341607
[TBL] [Abstract][Full Text] [Related]
12. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Basu R; Basu A; Nielsen M; Shah P; Rizza RA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
[TBL] [Abstract][Full Text] [Related]
13. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
14. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
[TBL] [Abstract][Full Text] [Related]
15. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
Murayama Y; Kawai K; Watanabe Y; Yoshikawa H; Yamashita K
J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170
[TBL] [Abstract][Full Text] [Related]
16. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
[TBL] [Abstract][Full Text] [Related]
17. Impairment of noninsulin-mediated glucose disposal in the elderly.
Meneilly GS; Elahi D; Minaker KL; Sclater AL; Rowe JW
J Clin Endocrinol Metab; 1989 Mar; 68(3):566-71. PubMed ID: 2563735
[TBL] [Abstract][Full Text] [Related]
18. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
Cuthbertson J; Patterson S; O'Harte FP; Bell PM
Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
[TBL] [Abstract][Full Text] [Related]
19. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
[TBL] [Abstract][Full Text] [Related]
20. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
